Effect of Alemtuzumab vs. Interferon beta-1a on Brain Atrophy in Patients with Early, Active Relapsing-Remitting Multiple Sclerosis

被引：0
|
作者：
Zivadinov, Robert
Dwyer, Michael
Bergsland, Niels
Hussein, Sara
Durfee, Jackie
Ramasamy, Deepa
Cherneva, Mariya
Willis, Laura
Cox, Jennifer
Kennedy, Cheryl
Margolin, David
Rizzo, Marco
Palmer, Jeffrey
机构：
来源：
NEUROLOGY | 2011年 / 76卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A388 / A388
页数：1
相关论文
共 50 条
  • [31] Brain atrophy in relapsing-remitting multiple sclerosis patients treated with interferon-beta and atorvastatin (The ARIANNA study)
    Lanzillo, R.
    Quarantelli, M.
    Veria, V.
    Orefice, G.
    Marrosu, M. G.
    Trojano, M.
    Amato, M. P.
    Francia, A. M.
    Florio, C.
    Tedeschi, G.
    Bellantonio, P.
    Annunziata, P.
    Comerci, M.
    Brunetti, A.
    Bonavita, V.
    Alfano, B.
    Marini, S.
    Pozzilli, C.
    Morra, V. Brescia
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 58 - 58
  • [32] Binding and Neutralising Antibodies in Relapsing-remitting Multiple Sclerosis Patients Treated with a Biosimilar Interferon Beta-1a (CinnoVex®)
    Sh, Nafissi
    Shahkarami, M. Amir
    Lam, R.
    Oger, J.
    MULTIPLE SCLEROSIS, 2010, 16 (02): : 273 - 273
  • [33] Influence of histocompatibility genes on the clinical course of patients with relapsing-remitting multiple sclerosis treated with interferon beta-1a
    Fletcher, S.
    Klein, T.
    Pollak, L.
    MULTIPLE SCLEROSIS, 2007, 13 : S200 - S201
  • [34] Alemtuzumab: A new therapy for active relapsing-remitting multiple sclerosis
    Hartung, Hans-Peter
    Aktas, Orhan
    Boyko, Alexey N.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (01) : 22 - 34
  • [35] Improvement in MRI outcomes across subgroups with alemtuzumab versus interferon beta-1a in treatment-naive relapsing-remitting multiple sclerosis
    Montalban, X.
    Arnold, D. L.
    Fisher, E.
    Margolin, D. H.
    Palmer, J.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 83 - 84
  • [36] Peginterferon Beta-1a: A Review of Its Use in Patients with Relapsing-Remitting Multiple Sclerosis
    Sheridan M. Hoy
    CNS Drugs, 2015, 29 : 171 - 179
  • [37] Peginterferon Beta-1a: A Review of Its Use in Patients with Relapsing-Remitting Multiple Sclerosis
    Hoy, Sheridan M.
    CNS DRUGS, 2015, 29 (02) : 171 - 179
  • [38] Effect of alemtuzumab on quality of life in patients with relapsing-remitting multiple sclerosis
    Bass, Ann
    MULTIPLE SCLEROSIS, 2009, 15 (11): : 1396 - 1396
  • [39] Health economic evaluation of interferon beta-1a versus interferon beta-1b for patients with relapsing-remitting multiple sclerosis in Switzerland
    Nuijten, M. J. C.
    Chofflon, M.
    MULTIPLE SCLEROSIS, 2007, 13 : S262 - S262
  • [40] Alemtuzumab versus interferon beta-1a in early multiple sclerosis
    Dennis Bourdette
    Vijayshree Yadav
    Current Neurology and Neuroscience Reports, 2009, 9 (5) : 341 - 342
12345